Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.
2.

The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Kingsberg SA, Simon JA, Goldstein I.

J Sex Med. 2008 Sep 2;5 Suppl 4:182-93; quiz 193. doi: 10.1111/j.1743-6109.2008.00961.x. Review.

PMID:
18783534
3.

The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.

Sills T, Wunderlich G, Pyke R, Segraves RT, Leiblum S, Clayton A, Cotton D, Evans K.

J Sex Med. 2005 Nov;2(6):801-18.

PMID:
16422805
4.

The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.

Zimmerman Y, Eijkemans MJ, Coelingh Bennink HJ, Blankenstein MA, Fauser BC.

Hum Reprod Update. 2014 Jan-Feb;20(1):76-105. doi: 10.1093/humupd/dmt038. Epub 2013 Sep 29. Review.

5.

Female hypoactive sexual desire disorder: History and current status.

Segraves R, Woodard T.

J Sex Med. 2006 May;3(3):408-18. Review.

PMID:
16681466
6.

Endocrine aspects of female sexual dysfunction.

Davis SR, Guay AT, Shifren JL, Mazer NA.

J Sex Med. 2004 Jul;1(1):82-6. Review.

PMID:
16422987
7.

Hypoactive sexual desire disorder.

Davison SL.

Curr Opin Obstet Gynecol. 2012 Aug;24(4):215-20. doi: 10.1097/GCO.0b013e328355847e. Review.

PMID:
22729093
8.
9.

Low sexual desire--is it all in her head? Pathophysiology, diagnosis, and treatment of hypoactive sexual desire disorder.

Simon JA.

Postgrad Med. 2010 Nov;122(6):128-36. doi: 10.3810/pgm.2010.11.2230. Review.

PMID:
21084789
10.

Testosterone therapy in women: a review.

Bolour S, Braunstein G.

Int J Impot Res. 2005 Sep-Oct;17(5):399-408. Review.

PMID:
15889125
11.

Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.

Kingsberg SA, Althof SE.

J Sex Med. 2011 Dec;8(12):3262-70. doi: 10.1111/j.1743-6109.2011.02447.x. Epub 2011 Aug 24. Review.

PMID:
21883949
12.

Loss of sexual desire in the postmenopausal woman.

Wylie K, Daines B, Jannini EA, Hallam-Jones R, Boul L, Wilson L, Athanasiadis L, Brewster M, Kristensen E.

J Sex Med. 2007 Mar;4(2):395-405. Review.

PMID:
17367435
13.

Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women.

Palacios S.

Womens Health (Lond). 2011 Jan;7(1):95-107. doi: 10.2217/whe.10.81. Review.

14.

The influence of combined oral contraceptives on female sexual desire: a systematic review.

Pastor Z, Holla K, Chmel R.

Eur J Contracept Reprod Health Care. 2013 Feb;18(1):27-43. doi: 10.3109/13625187.2012.728643. Review.

PMID:
23320933
15.

The DSM diagnostic criteria for Hypoactive Sexual Desire Disorder in men.

Brotto LA.

J Sex Med. 2010 Jun;7(6):2015-30. doi: 10.1111/j.1743-6109.2010.01860.x. Review.

PMID:
20929517
16.

Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?

Schover LR.

Fertil Steril. 2008 Jul;90(1):129-40. Epub 2007 Nov 26. Review.

PMID:
18023435
17.

The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.

Krapf JM, Simon JA.

Maturitas. 2009 Jul 20;63(3):213-9. doi: 10.1016/j.maturitas.2009.04.008. Epub 2009 May 31. Review.

PMID:
19487090
18.

Two novel combined drug treatments for women with hypoactive sexual desire disorder.

Poels S, Bloemers J, van Rooij K, Koppeschaar H, Olivier B, Tuiten A.

Pharmacol Biochem Behav. 2014 Jun;121:71-9. doi: 10.1016/j.pbb.2014.02.002. Epub 2014 Feb 15. Review.

PMID:
24534417
19.

Role of testosterone in the treatment of hypoactive sexual desire disorder.

Schwenkhagen A, Studd J.

Maturitas. 2009 Jun 20;63(2):152-9. doi: 10.1016/j.maturitas.2009.02.011. Epub 2009 Apr 8. Review.

PMID:
19359109
20.

Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment.

Warnock JJ.

CNS Drugs. 2002;16(11):745-53. Review.

PMID:
12383030
Items per page

Supplemental Content

Write to the Help Desk